Public Citizen Calls on FDA to Pull Gout Drug Due to CV Risk Public Citizen Calls on FDA to Pull Gout Drug Due to CV Risk

The nonprofit advocacy group says there is ' overwhelming evidence that the serious cardiovascular harms of febuxostat outweigh any purported clinical benefit, ' citing CARES postmarket data.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news